DAVENPORT FRED B JR 4
4 · Medpace Holdings, Inc. · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Medpace (MEDP) Director Fred B. Davenport Jr Receives Award
What Happened
- Fred B. Davenport Jr., a director of Medpace Holdings, Inc. (MEDP), was granted 1,110 derivative shares (an equity award/option-type grant) on May 15, 2026. The reported acquisition price is $0.00 (typical for a grant); no cash was paid by the insider at grant.
Key Details
- Transaction date: 2026-05-15; filing date: 2026-05-18 (filed within the SEC’s required period).
- Award: 1,110 derivative shares; reported price $0.00 (grant).
- Shares owned after transaction: not specified in the reported Form 4.
- Footnotes: F1 — award is held in a trust for the reporting person’s benefit. F2 — the option vests on the earlier of (i) the day before the issuer’s first annual meeting after grant or (ii) the first anniversary of grant, subject to continued board service.
- Transaction code: A (award/grant).
Context
- This is a director compensation award, not an open‑market purchase or sale. Such grants are commonly used to compensate directors and typically vest over time; they do not necessarily indicate immediate buying or selling of stock.
Insider Transaction Report
Form 4
DAVENPORT FRED B JR
Director
Transactions
- Award
Stock Option (Right to Buy)
[F2]2026-05-15+1,110→ 1,110 totalExercise: $415.27Exp: 2033-05-15→ Common Stock (1,110 underlying)
Holdings
- 3,498
Common Stock
- 2,000(indirect: By Trust)
Common Stock
[F1]
Footnotes (2)
- [F1]Owned by trust for the benefit of the Reporting Person.
- [F2]The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for Fred B. Davenport, Jr.|2026-05-18